Mirtazapine and Bactroban drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mirtazapine (mirtazapine) and Bactroban (mupirocin). Common drug interactions include acute respiratory failure among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Mirtazapine and Bactroban. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Mirtazapine?

Mirtazapine has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 82,120 Mirtazapine users. Check the latest studies of Mirtazapine.

What is Bactroban?

Bactroban has active ingredients of mupirocin. It is often used in infection. eHealthMe is studying from 4,967 Bactroban users. Check the latest studies of Bactroban.



On Jul, 09, 2026

52 people who take Mirtazapine and Bactroban together, and have interactions are studied.

Mirtazapine and Bactroban drug interactions.

What are the common drug interactions of Mirtazapine and Bactroban, by gender? *:

female:

  1. Acute respiratory failure
  2. Acute sinusitis
  3. Affective disorder (mental disorder)
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Anaemia (lack of blood)
  6. Anastomotic leak
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  9. Aortic valve sclerosis (narrowing of the aortic valve)
  10. Appetite disorder (abnormal eating habits)

male:

  1. Acute respiratory failure
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Chronic kidney disease
  5. Emotional distress
  6. Hallucination, auditory (perceiving sounds without auditory stimulus)
  7. Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)
  8. Myalgia (muscle pain)
  9. Osteopenia (a condition where bone mineral density is lower than normal)
  10. Pain

What are the common drug interactions of Mirtazapine and Bactroban, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Acute respiratory failure
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Pyrexia (fever)
  4. Respiratory tract infection
  5. Biliary tract disorder
  6. Gastritis (inflammation of stomach)
  7. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  8. Respiration (transport of oxygen from the outside air to the cells within tissues)
  9. Urinary tract infection
  10. Viral infection

10-19:

n/a

20-29:

  1. Pneumonia
  2. Fall
  3. Hyperglycaemia (high blood sugar)
  4. Hypoglycaemia (deficiency of glucose in the bloodstream)
  5. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  6. Joint swelling

30-39:

n/a

40-49:

  1. Blood potassium decreased
  2. Blood sodium decreased
  3. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  4. Injury
  5. Proteinuria (presence of protein in the urine)
  6. Dyspepsia (indigestion)
  7. Multiple injuries
  8. Renal failure (kidney dysfunction)
  9. Anaphylactic reaction (serious allergic reaction)
  10. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)

50-59:

n/a

60+:

  1. Rib fracture
  2. Atypical femur fracture
  3. Back pain
  4. Fall
  5. Nausea (feeling of having an urge to vomit)
  6. Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
  7. Spinal disorder (disease of spine a back bone)
  8. Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances)
  9. Abdominal distension
  10. Abdominal infection

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 19.23%
  2. Pain: 8 people, 15.38%
  3. Neuralgia (pain in one or more nerves): 8 people, 15.38%
  4. Seasonal Allergy (allergic condition due to certain season): 7 people, 13.46%
  5. Cough: 7 people, 13.46%
  6. Nausea (feeling of having an urge to vomit): 7 people, 13.46%
  7. High Blood Pressure: 7 people, 13.46%
  8. Asthma: 6 people, 11.54%
  9. Diabetes: 6 people, 11.54%
  10. Fungal Infection: 6 people, 11.54%

* Approximation only. Some reports may have incomplete information.

Do you take Mirtazapine and Bactroban?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mirtazapine and Bactroban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mirtazapine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bactroban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mirtazapine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bactroban and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mirtazapine and mupirocin (the active ingredients of Mirtazapine and Bactroban, respectively), and Mirtazapine and Bactroban (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: